nohealthproblemsnews.com
Home »
MONDAY, Oct. 22, 2018 — For patients with metastatic triple-negative breast cancer, atezolizumab plus nanoparticle albumin-bound (nab)-paclitaxel prolongs progression-free survival […] About 15 percent of breast cancers are classified as triple-negative, lacking receptors for estrogen, progesterone, and Her2. These cancers do […]
Chemoimmunotherapy Ups Survival in Triple-Negative Breast Cancer
Immune cells in triple-negative breast cancer offer potential therapeutic target
